Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Sandu Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Revenue

₹671.9 M

FY, 2025

CreditSafe Score

?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024FY, 2025
Revenue490.2M494.2M483.7M587.2M655.0M653.5M672.8M671.9M
Cost of goods sold283.9M253.1M251.1M345.0M357.4M311.9M325.7M321.0M
Gross profit206.2M242.3M232.5M242.6M297.6M341.6M347.1M350.9M
Gross profit margin, %48.1%41.3%45.4%52.3%51.6%52.2%
Operating expense total181.6M220.2M218.0M219.7M268.4M316.3M323.7M321.6M
Depreciation and amortization6.0M6.4M5.5M5.6M5.3M5.2M5.8M6.7M
EBITDA24.7M22.1M14.6M22.8M29.1M25.2M23.4M29.3M
EBITDA margin, %3.0%3.9%4.4%3.9%3.5%4.4%
EBIT19.1M15.7M12.8M17.3M23.8M20.1M17.6M22.6M
EBIT margin, %2.6%2.9%3.6%3.1%2.6%3.4%
Interest income233.0K4.6M677.0K1.9M764.0K1.6M1.6M1.7M
Interest expense12.3M10.1M4.3M1.1M1.1M796.0K630.0K1.0M
Pre tax profit7.6M10.2M9.2M16.8M23.2M22.2M20.7M21.6M
Income tax expense1.9M3.5M2.0M5.9M7.3M7.0M6.1M6.1M
Net Income5.6M6.7M7.2M10.9M15.9M15.2M14.6M15.5M

Footer menu